These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1486427)

  • 1. Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment.
    Low SC; Dixon AR; Bell J; Ellis IO; Elston CW; Robertson JF; Blamey RW
    Br J Surg; 1992 Dec; 79(12):1314-6. PubMed ID: 1486427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERICA predicts response to tamoxifen in elderly women with breast cancer.
    Davies N; Moir G; Carpenter R; Cuthbert A; Herbert A; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1991 Nov; 73(6):361-3. PubMed ID: 1759765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for primary tamoxifen therapy in elderly women with breast cancer.
    Gaskell DJ; Hawkins RA; de Carteret S; Chetty U; Sangster K; Forrest AP
    Br J Surg; 1992 Dec; 79(12):1317-20. PubMed ID: 1486428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
    Swain SM; Wilson JW; Mamounas EP; Bryant J; Wickerham DL; Fisher B; Paik S; Wolmark N
    J Natl Cancer Inst; 2004 Apr; 96(7):516-23. PubMed ID: 15069113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.
    Chakrabarti J; Kenny FS; Syed BM; Robertson JF; Blamey RW; Cheung KL
    Crit Rev Oncol Hematol; 2011 Jun; 78(3):260-4. PubMed ID: 20447833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients.
    Akhtar SS; Allan SG; Rodger A; Chetty UD; Smyth JF; Leonard RC
    Eur J Surg Oncol; 1991 Feb; 17(1):30-5. PubMed ID: 1995354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.
    Gaskell DJ; Hawkins RA; Sangsterl K; Chetty U; Forrest AP
    Lancet; 1989 May; 1(8646):1044-6. PubMed ID: 2566000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
    Clarke RB; Laidlaw IJ; Jones LJ; Howell A; Anderson E
    Br J Cancer; 1993 Mar; 67(3):606-11. PubMed ID: 8439511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.
    Soubeyran I; Quénel N; Coindre JM; Bonichon F; Durand M; Wafflart J; Mauriac L
    Br J Cancer; 1996 Oct; 74(7):1120-5. PubMed ID: 8855985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differing predictive values of oestrogen receptor assays for large breast cancers.
    Gaskell DJ; Hawkins RA; Tesdale AL; Sangster K; Chetty U; Forrest AP
    Postgrad Med J; 1992 Nov; 68(805):900-3. PubMed ID: 1494511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
    Holdaway IM
    Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
    al-Alwan NA; al-Kubaisy W; al-Rawaq K
    East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
    Hoff PM; Valero V; Buzdar AU; Singletary SE; Theriault RL; Booser D; Asmar L; Frye D; McNeese MD; Hortobagyi GN
    Cancer; 2000 May; 88(9):2054-60. PubMed ID: 10813717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
    Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women.
    Daidone MG; Luisi A; Martelli G; Benini E; Veneroni S; Tomasic G; De Palo G; Silvestrini R
    Br J Cancer; 2000 Jan; 82(2):270-7. PubMed ID: 10646876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Ciocca D; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; O'Sullivan J; Martino S; Osborne CK
    Clin Cancer Res; 1998 Jan; 4(1):7-12. PubMed ID: 9516946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trials.
    Dhodapkar MV; Ingle JN; Cha SS; Mailliard JA; Wieand HS
    Cancer; 1996 Feb; 77(4):683-90. PubMed ID: 8616760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.